Harness the Expanding Analytical Toolbox & Ensure Process Quality at Every Phase to Demonstrate Safety, Efficacy & Consistency of Gene Therapies to Regulators
Welcome to the 6th Gene Therapy Analytical Development & CMC Summit
Execute Robust Analytical & Process Development Strategies for Complex Gene Therapies
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.
Your Complete Guide to the Meeting is Here:
Previously Attending Companies Include:
"Gene Therapy Analytical Summit is a one-of-a-kind conference where focus is on analytical methods for gene therapy. This focused conference brings together expertise, findings and conversation around current challenges. It is a very relevant and meaningful conferences the best conference in the field"
Binod Pandey, Senior Scientist, Novartis
Our Senior Partners:
Other Events In The Gene Therapy Series:
